Bausch + Lomb Corp reports results for the quarter ended March 31 - Earnings Summary

• Bausch + Lomb Corp BLCO.N reported a quarterly adjusted loss of 7 cents​​ per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of 7 cents. The mean expectation of thirteen analysts for the quarter was for earnings of 3 cents per share. Wall Street expected results to range from -1 cents to 15 cents per share.

• Revenue rose 3.5% to $1.14 billion from a year ago; analysts expected $1.15 billion.

• Bausch + Lomb Corp's reported EPS for the quarter was a loss of 60 cents​.

• The company reported a quarterly loss of $212 million.

• Bausch + Lomb Corp shares had fallen by 5.4% this quarter and lost 24.0% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 76.2% in the last three months.​

• In the last 30 days, one analyst negatively revised an earnings estimate

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 5 "strong buy" or "buy," 7 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "hold"

• Wall Street's median 12-month price target for Bausch + Lomb Corp is $18.49

This summary was machine generated from LSEG data April 30 at 01:32 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)